Looking Into Recursion Pharmaceuticals's Recent Short Interest
Portfolio Pulse from Benzinga Insights
Recursion Pharmaceuticals (NYSE:RXRX) has seen a 7.4% increase in short interest since the last report, with 35.50 million shares shorted, representing 25.83% of its float. The short interest is higher than the peer group average of 13.79%. High short interest can indicate bearish market sentiment but can also be bullish if it leads to a short squeeze.
December 06, 2023 | 4:45 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Recursion Pharmaceuticals' short interest has increased, indicating potential bearish sentiment or a setup for a short squeeze.
While the increase in short interest suggests that the market may be bearish on RXRX, it could also lead to a short squeeze if the stock price starts to rise, causing shorts to cover their positions. The impact is neutral in the short term as it could go either way depending on market dynamics and investor reactions.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100